Effects of olanzapine on serum protein phosphorylation patterns in patients with schizophrenia

Jaros J. A., Rahmoune H., Wesseling H., Leweke F. M., Ozcan S., Guest P. C., ...Daha Fazla

PROTEOMICS CLINICAL APPLICATIONS, cilt.9, ss.907-916, 2015 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 9
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1002/prca.201400148
  • Dergi Adı: PROTEOMICS CLINICAL APPLICATIONS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.907-916
  • Anahtar Kelimeler: Biomarker, Drug response, Monitoring, Proteomics, Serum, APOLIPOPROTEIN-A-I, VENOUS THROMBOEMBOLISM, ANTIPSYCHOTIC-DRUGS, PROTEOMIC ANALYSIS, PLASMA, BLOOD, RISK, IDENTIFICATION, EXPRESSION, CLOZAPINE
  • Orta Doğu Teknik Üniversitesi Adresli: Hayır

Özet

Purpose Previous studies have shown that blood serum phosphoproteins are altered in schizophrenia patients in comparison to controls. However, it is not known whether phosphoproteins are also changed in response to treatment with antipsychotics.